Crossmark

Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study

Crossref DOI link: https://doi.org/10.1186/s12916-022-02349-6

Published Online: 2022-05-04

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Livingstone, Shona J.

Guthrie, Bruce

Donnan, Peter T.

Thompson, Alexander

Morales, Daniel R. http://orcid.org/0000-0002-0063-8069
Funding

Funding for this research was provided by:

National Institute for Health Research

Wellcome Trust
License Information

Text and Data Mining valid from 2022-05-04

Version of Record valid from 2022-05-04
More Information

Article History

Received: 17 January 2022

Accepted: 23 March 2022

First Online: 4 May 2022

Declarations

:

: The study was approved by the Clinical Practice Research Datalink Independent Scientific Advisory Committee (ISAC) protocol 16_248. No consent was required other than the CPRD ISAC approval.

: Not applicable.

: Dr. Donnan reports a grant from AbbVie, outside the submitted work, and is a member of the NHS Scottish Medicines Consortium. The others authors declare that they have no competing interests.

Document is current

Any future updates will be listed below